1. Home
  2. BAER vs GNLX Comparison

BAER vs GNLX Comparison

Compare BAER & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridger Aerospace Group Holdings Inc.

BAER

Bridger Aerospace Group Holdings Inc.

HOLD

Current Price

$1.94

Market Cap

113.0M

Sector

Finance

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$3.03

Market Cap

133.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAER
GNLX
Founded
2014
2001
Country
United States
United States
Employees
235
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
113.0M
133.0M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
BAER
GNLX
Price
$1.94
$3.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$5.00
$17.25
AVG Volume (30 Days)
455.5K
190.8K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
9.47
EPS
N/A
N/A
Revenue
N/A
$8,000.00
Revenue This Year
$16.47
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.47
$2.29
52 Week High
$3.44
$8.54

Technical Indicators

Market Signals
Indicator
BAER
GNLX
Relative Strength Index (RSI) 51.54 54.95
Support Level $1.58 $2.62
Resistance Level $1.97 $3.21
Average True Range (ATR) 0.10 0.16
MACD 0.02 0.01
Stochastic Oscillator 61.36 58.97

Price Performance

Historical Comparison
BAER
GNLX

About BAER Bridger Aerospace Group Holdings Inc.

Bridger Aerospace Group Holdings Inc operates as an aerial firefighting company. It provides aerial wildfire surveillance, relief and suppression, and aerial firefighting services using next-generation technology and environmentally friendly and sustainable firefighting methods. Its revenues is derived from aerial wildfire management, relief and suppression and the delivery of specialty aviation services. The company's portfolio is organized across three offerings namely : Fire Suppression; Aerial Surveillance; and Maintenance, Repair and Overhaul (MRO). The company operates as a single operating segment. Its revenues are derived from aerial wildfire management, relief and suppression and the delivery of specialty aviation service. Geographically, it operates in Spain and United States.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: